Anti-VEGF Therapies: Ocular and Systemic Impact
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
This continuing medical education (CME) activity captures content from a CME roundtable held in August of 2014 in Philadelphia, PA.A CME activity jointly sponsored by The Dulaney Foundation and Retina Today Supported by an educational grant from Regeneron Pharmaceuticals. Learning Objectives
Upon completion of this activity, participants should be able to: • Understand the most recent monotherapy and combination therapy clinical study evidence using available anti-VEGF therapies for common retinal diseases, including AMD, RVO, and DME • Appreciate the relevance of key assay methods to determine ocular and systemic effects of anti-VEGF therapies • Discuss the ocular and systemic effects of anti-VEGF therapies and how to educate patients on appropriate expectations • Develop plans to initiate treatment for conditions such as AMD, RVO, and DME using anti-VEGF agents, as well as better understand when to change therapeutic strategies Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dulaney Foundation and Retina Today. The Dulaney Foundation is accredited by the ACCME to provide continuing education for physicians. The Dulaney Foundation designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit. ™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
Thomas Albini, MD Associate Professor of Clinical Ophthalmology University of Miami Bascom Palmer Eye Institute Miami, FL Audina Berrocal, MD Professor of Clinical Ophthalmology University of Miami Bascom Palmer Eye Institute Miami, FL Peter K. Kaiser, MD, Professor of Ophthalmology Cleveland Clinic Lerner College of Medicine Staff Surgeon, Vitreoretinal Department Cole Eye Institute, Cleveland Clinic Cleveland, OH Rohit Ross Lakhanpal, MD Retina Specialist The Eye and Cosmetic Surgery Center Mercy Medical Center Baltimore, MD Andrew Moshfeghi, MD, MBA Associate Professor of Clinical Ophthalmology Director of Clinical Trials Unit University of Southern California Los Angeles, CA. Charles C. Wykoff, MD, PhD Clinical Assistant Professor of Ophthalmology Weill Cornell Medical College Retina Consultants of Houston Houston, TX Thomas Albini, MD: Allergan, Inc; Bausch + Lomb; Eleven Biotherapeutics; Genentech.; and ThromboGenics. Audina Berrocal, MD: No financial affiliations or disclosures: Peter K. Kaiser, MD: Alcon; Bayer AG; Novartis International, AG; Oraya Therapeutic; Regeneron Pharmaceuticals; ThromboGenics NV; and Valeant Pharmaceuticals International. Rohit Ross Lakhanpal, MD: Allergan; Alcon; and ThromboGenics. Andrew Moshfeghi, MD, MBA: Allergan; Alexion Pharmaceuticals; Genentech; and Regeneron Pharmaceuticals. Charles C. Wykoff, MD, PhD: Alcon; Allergan; Alimieria Sciences; Genentech; Regeneron Pharmaceuticals; Synergetics; and ThromboGenics. All of those involved in the planning, editing, and peer review of this educational activity report no relevant financial relationships.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The Dulaney Foundation, Retina Today, and Regeneron Pharmaceuticals. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
- CME/CE Broadcast Replay
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
1.00 creditDeepak Sambhara, MD
Katherine E. Talcott, MD
Roger A. Goldberg, MD, MBA
